Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B
Published 2 months, 1 week ago
Description
Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platform, and Sebastian Arana of MilliporeSigma talks through the real cost of manufacturing flexibility.